|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Accretion of interest on convertible note - related party | |||||
| Amortization of convertible note issuance costs | |||||
| Amortization of debt issuance costs | |||||
| Convertible Note | |||||
| Total amortization of debt issuance costs | |||||
| Amortization of debt discount due to modification of convertible note - related party | |||||
| Loss on extinguishment of debt | |||||
| Deferred financing costs written off | |||||
| Provision for bad debt | |||||
| Stock-based compensation expense | |||||
| Impairment of property, plant and equipment | |||||
| Loss on disposal of property, plant and equipment | |||||
| Deferred taxes | |||||
| Reduction in the carrying amount of operating lease right-of-use assets | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Operating lease and other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from employee stock option exercises | |||||
| Payments made for employee restricted stock tax withholdings | |||||
| Fees and issuance costs from registered direct offering of common stock | |||||
| Proceeds from employee stock purchase plan | |||||
| Fees and issuance costs from private placement of common stock | |||||
| Repayment of convertible note | |||||
| Repayment of term loan | |||||
| Proceeds from term loan | |||||
| Issuance costs from term loan and revolver | |||||
| Issuance costs from term loan and revolving line of credit | |||||
| Proceeds from revolving line of credit | |||||
| Repayment of revolving line of credit | |||||
| Proceeds from sale and leaseback transactions | |||||
| Repayment of lease and other finance obligations | |||||
| Repayment of finance obligation for sale and leaseback transactions | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental disclosures of non-cash activities: | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Capitalized Interest | |||||
| Changes in accrued capital expenditures | |||||
Loading...